Clinical Trial

Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 21, 2024 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study is a prospective, multicenter, single arm Phase II exploratory study. It is expected to include 24 first-line patients with small cell lung cancer who have progressed after 6 months of treatment with platinum containing regimens, and receive treatment with irinotecan liposomes combined with cisplatin or carboplatin regimens.
Trial Details
NCT Number NCT06467786
Lead Sponsor Tang-Du Hospital
Conditions Small Cell Lung Cancer
Enrollment 24 participants
Start Date 2024-03-15
Primary Completion 2025-09-15 (estimated)
Study Completion 2028-09-15 (estimated)
Updated on ClinicalTrials.gov 2024-06-21